VOLITIONRX LTD — Form 8-K
Filed October 27, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 62/100
What the filing says
VolitionRx made a $525,000 cash payment (including prepayment fee) on October 23, 2026 to reduce the principal on its $2.4M senior secured convertible note issued to Lind Global Asset Management XII LLC from $2.4M to $706,667. In exchange, Lind waived conversion rights until January 1, 2027 (unless stock closes ≥$0.275/share) and agreed to defer November–December 2026 monthly repayments. This is the company's second debt reduction with Lind; it also fully repaid a separate $7.5M note in September 2026.
Why this rating
Meaningful debt reduction (21% of $2.4M note, ~7% of $72.9M market cap) with favorable conversion waiver; demonstrates cash position and lender confidence, but company remains highly leveraged.
See more from October 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.